Information  X 
Enter a valid email address

Diurnal Group PLC Ord GBP0.05 (DNL)

Date Time Source Announcement
17 Sep 2020 12:40 pm
EQS
Diurnal Group (DNL): Closely watching the regulators
15 Sep 2020 7:00 am
RNS
Results for the year ended 30 June 2020
11 Sep 2020 7:00 am
RNS
Shares and AJ Bell Investor Evening Webinar
03 Sep 2020 5:33 pm
RNS
Holdings in Company
  7:00 am
RNS
Two further marketing and distribution agreements
27 Aug 2020 7:00 am
RNS
Richard Ross receives honour by Endocrine Society
20 Aug 2020 7:15 am
EQS
Diurnal Group (DNL): Q&A with Dr Martin Hall
19 Aug 2020 10:00 am
RNS
Notice of Full Year Results
13 Aug 2020 2:06 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  7:15 am
EQS
Diurnal Group (DNL): Flow of regulatory approvals
10 Aug 2020 9:14 am
RNS
Holding(s) in Company
  7:00 am
RNS
Alkindi approved in Australia
05 Aug 2020 7:00 am
RNS
Alkindi approved in Israel
30 Jul 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  2:06 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  7:01 am
RNS
Business and trading update
  7:00 am
RNS
Positive DITEST Regulatory Meeting with US FDA
29 Jul 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
15 Jul 2020 1:04 pm
RNS
Director Dealings
13 Jul 2020 1:29 pm
RNS
Director Dealings and Issue of Equity
  1:28 pm
RNS
Grant of Deferred Share Awards
26 Jun 2020 2:29 pm
RNS
Director Dealings
09 Jun 2020 7:00 am
RNS
Chronocort Phase 3 data at ENDO Online 2020
29 May 2020 7:00 am
RNS
Change of Adviser
30 Apr 2020 9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
21 Apr 2020 10:05 am
RNS
Director Dealings and Issue of Equity
16 Apr 2020 2:23 pm
RNS
Director Dealings
15 Apr 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
Operational Update
06 Apr 2020 9:21 am
RNS
Director Dealings
01 Apr 2020 7:00 am
RNS
Chronocort MAA Passes Validation Stage with EMA
30 Mar 2020 6:18 pm
RNS
Holding(s) in Company
  3:05 pm
EQS
Diurnal (DNL): $52.5m US deal strengthens balance sheet further
27 Mar 2020 5:26 pm
RNS
Holding(s) in Company
  9:17 am
RNS
Director Dealings
  7:00 am
RNS
US Licencing Agreement with Eton Pharmaceuticals
26 Mar 2020 2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
25 Mar 2020 2:47 pm
RNS
Result of General Meeting and Issue of Equity
20 Mar 2020 4:48 pm
RNS
Second Price Monitoring Extn
  4:39 pm
RNS
Price Monitoring Extension
06 Mar 2020 4:55 pm
RNS
Result of Placing and Notice of General Meeting
  11:22 am
RNS
Proposed Placing
05 Mar 2020 4:41 pm
RNS
Directorate Change
28 Feb 2020 7:30 am
EQS
Diurnal (DNL): . and more to come (news flow)
25 Feb 2020 3:06 pm
RNS
Holding(s) in Company
20 Feb 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
  11:00 am
RNS
Price Monitoring Extension
17 Feb 2020 1:46 pm
RNS
Holding(s) in Company
13 Feb 2020 7:00 am
RNS
US FDA Accepts NDA Application for Alkindi
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t